Hypothesizing that therapeutic use of DEL-1 might be an interesting and effective way to attenuate hypertension-induced cardiovascular remodeling, Failer and colleagues performed an excellent study to address a potential beneficial effect of therapeutic DEL-1 in hypertension-induced cardiovascular disease [7]. The gene discussed is EDIL3; the disease is cardiovascular disorder.